MoH DHA and EDE attended WHX 2026, demonstrating their firm commitment to making the UAE's hospital and pharmaceutical sector increasingly competitive and regulated in accordance with the highest global standards. 

This is demonstrated by EDE's establishment within the MoH and the monitoring and consulting activities it provides daily to all local and international companies. 
This edition of WHX confirms Dubai's position as one of the world's most important hubs for hospital and healthcare technologies, as well as for the pharmaceutical market. 

For eXinvest of Emirates, it was an event where our teams were able to gather feedback from the activities carried out in 2025 and focus on new resources to offer in 2026. 

For Finchemo, it was the first edition where we were able to meet potential companies in which to invest and in which to channel our commercial potential and expertise.

See you next year!

www.exinvest.ae
www.finchemo.com

This email address is being protected from spambots. You need JavaScript enabled to view it.
This email address is being protected from spambots. You need JavaScript enabled to view it.